Duality Biotherapeutics, Inc. (HKG:9606)
277.80
-2.20 (-0.79%)
Apr 29, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 25.29 billion as of April 29, 2026.
Market Cap
25.29B
Enterprise Value
21.70B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
277.80
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 25.29B, an increase of 44.38%. That is a compound annual growth rate of 42.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 25.09B | -5.91% |
| Dec 31, 2025 | 26.66B | 52.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 25.75B |
| TransThera Sciences (Nanjing) | 22.75B |
| InnoCare Pharma | 28.40B |
| Keymed Biosciences | 22.17B |
| Genscript Biotech | 29.60B |
| Zai Lab | 19.27B |
| Ascletis Pharma | 17.70B |
| Ascentage Pharma Group International | 16.91B |